Announcement on FDA Approval for BAT2206 (Ustekinumab) Injection in the United States

About this update from Bio-thera Solutions, Ltd. Class A

Announcement on FDA Approval for BAT2206 (Ustekinumab) Injection in the United States The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Bio-thera Solutions, Ltd. Class A